4.6 Article

How the CORAL software can be used to select compounds for efficient treatment of neurodegenerative diseases?

Journal

TOXICOLOGY AND APPLIED PHARMACOLOGY
Volume 408, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.taap.2020.115276

Keywords

Alzheimer's Disease; Parkinson's Disease; Neuroprotection; Neurodegenerative Diseases; Bioinformatics; In Silico Design

Funding

  1. NSF-CREST [HRD 154774]
  2. project LIFE-CONCERT contract [LIFE17 GIE/IT/000461]

Ask authors/readers for more resources

Recommendations on the efficient application of CORAL software (http://www.insilico.eu/coral) to establish quantitative structure-property/activity relationships (QSPRs/QSARs) are provided. The predictive potential of the approach has been demonstrated for QSAR models developed for inhibitor concentrations (negative decimal logarithm of IC50) of derivatives of N-methyl-D-aspartate (NMDA) receptor, leucine-rich repeat kinase 2 (LRRK2), and tropomyosin receptor kinase A (TrkA). The above three protein targets are related to various neurodegenerative diseases such as Alzheimer's and Parkinson's. Each model was checked using several splits of the data for the training and the validation sets. The index of ideality of correlation (IIC) represents a tool to improve the predictive potential for an arbitrary model. However, the use of the IIC should be carried out according to rules, described in this work.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available